Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte apoptotic process.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of leukocyte apoptotic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SYK | spleen tyrosine kinase | 0.996 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.910 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.855 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.855 | Mouse | |
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.844 | ||
| INSR | insulin receptor | 0.779 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.726 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.680 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.607 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.595 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.566 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.557 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.521 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.483 | Human | |
| EGFR | epidermal growth factor receptor | 0.467 | ||
| BID | BH3 interacting domain death agonist | 0.452 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.447 | ||
| SH2D4A | SH2 domain containing 4A | 0.430 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.425 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.416 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.392 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.387 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.326 | Human | |
| AXL | AXL receptor tyrosine kinase | 0.292 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.291 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.259 | ||
| GAS6 | growth arrest-specific 6 | 0.256 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.252 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.228 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.216 | ||
| LAT | linker for activation of T cells | 0.207 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.204 | ||
| DERL1 | Der1-like domain family, member 1 | 0.169 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.165 | ||
| MSN | moesin | 0.151 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.142 | ||
| TNF | tumor necrosis factor | 0.133 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.124 | ||
| EPOR | erythropoietin receptor | 0.123 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.111 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.105 | Mouse | |
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.103 | ||
| IL8 | interleukin 8 | 0.100 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.097 | ||
| IL1B | interleukin 1, beta | 0.095 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.093 | Human | |
| SH3BP2 | SH3-domain binding protein 2 | 0.093 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.086 | Human | |
| NOXA1 | NADPH oxidase activator 1 | 0.085 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.085 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.075 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.073 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.069 | Rat | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.068 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.067 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.067 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.066 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.065 | Human | |
| PLEK | pleckstrin | 0.062 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.060 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.058 | ||
| VCP | valosin containing protein | 0.055 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.055 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.055 | ||
| IRS1 | insulin receptor substrate 1 | 0.054 | ||
| C9orf89 | chromosome 9 open reading frame 89 | 0.054 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.053 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.052 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.051 | Human | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.050 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.048 | ||
| IL2RB | interleukin 2 receptor, beta | 0.047 | ||
| PTAFR | platelet-activating factor receptor | 0.045 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.045 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.044 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.042 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.042 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.040 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.038 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.037 | ||
| FSTL1 | follistatin-like 1 | 0.037 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.037 | ||
| KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.037 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.037 | ||
| HCK | hemopoietic cell kinase | 0.037 | ||
| IFNG | interferon, gamma | 0.036 | ||
| PLXNB1 | plexin B1 | 0.034 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.034 | Human | |
| HK3 | hexokinase 3 (white cell) | 0.034 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.034 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.034 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.033 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.032 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.032 | Human | |
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.031 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.030 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.030 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.030 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.028 | Human | |
| SOCS3 | suppressor of cytokine signaling 3 | 0.028 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.028 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.028 | ||
| CSK | c-src tyrosine kinase | 0.028 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.028 | Human | |
| STAT5A | signal transducer and activator of transcription 5A | 0.028 | Mouse | |
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.027 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.027 | ||
| PRKCZ | protein kinase C, zeta | 0.027 | Human | |
| ARRB1 | arrestin, beta 1 | 0.026 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.026 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.026 | ||
| IL10 | interleukin 10 | 0.024 | ||
| MAGEA11 | melanoma antigen family A, 11 | 0.024 | ||
| TYMP | thymidine phosphorylase | 0.024 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.023 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.023 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.022 | ||
| IDE | insulin-degrading enzyme | 0.022 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.022 | ||
| CD86 | CD86 molecule | 0.021 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.021 | Mouse | |
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.021 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.020 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.020 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.020 | Human | |
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.020 | Rat | |
| IL18RAP | interleukin 18 receptor accessory protein | 0.019 | ||
| CD48 | CD48 molecule | 0.019 | ||
| BCL2A1 | BCL2-related protein A1 | 0.019 | Mouse | |
| EP300 | E1A binding protein p300 | 0.019 | ||
| PRKCB | protein kinase C, beta | 0.019 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.019 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.019 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.019 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.018 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.018 | Human | |
| CD2 | CD2 molecule | 0.018 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.018 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.017 | ||
| EZR | ezrin | 0.016 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.016 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.016 | ||
| DCTN1 | dynactin 1 | 0.016 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.015 | Mouse | |
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.015 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.015 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.015 | ||
| SLAMF7 | SLAM family member 7 | 0.015 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.015 | ||
| FPR3 | formyl peptide receptor 3 | 0.015 | ||
| AQP9 | aquaporin 9 | 0.015 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.015 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.014 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.014 | ||
| CD83 | CD83 molecule | 0.014 | ||
| BLNK | B-cell linker | 0.014 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.014 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.014 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.014 | ||
| TRIM9 | tripartite motif containing 9 | 0.013 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.013 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.013 | ||
| GHR | growth hormone receptor | 0.013 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.013 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.013 | ||
| IRF4 | interferon regulatory factor 4 | 0.013 | ||
| TOP3A | topoisomerase (DNA) III alpha | 0.012 | ||
| IL32 | interleukin 32 | 0.012 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.012 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.012 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.012 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.012 | ||
| DERL2 | Der1-like domain family, member 2 | 0.012 | ||
| IL7R | interleukin 7 receptor | 0.012 | ||
| FHL1 | four and a half LIM domains 1 | 0.012 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.012 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.012 | ||
| CD28 | CD28 molecule | 0.012 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.011 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.011 | ||
| MEST | mesoderm specific transcript homolog (mouse) | 0.011 | ||
| C3AR1 | complement component 3a receptor 1 | 0.011 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.011 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.011 | ||
| MARCO | macrophage receptor with collagenous structure | 0.011 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.011 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.010 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.010 | ||
| VCAN | versican | 0.010 | ||
| IL4R | interleukin 4 receptor | 0.010 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.010 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.010 | ||
| CD163 | CD163 molecule | 0.010 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.010 | ||
| HERPUD1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 0.010 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.010 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.010 |